<DOC>
	<DOCNO>NCT00720915</DOCNO>
	<brief_summary>The purpose study determine risk recurrent venous thromboembolism ( VTE ) stop therapy low acceptable patient first unprovoked proximal deep vein thrombosis ( DVT ) pulmonary embolism ( PE ) complete 3 month therapy negative D-dimer test therapy 1 month stop therapy .</brief_summary>
	<brief_title>D-dimer Select Patients With First Unprovoked Venous Thromboembolism Who Can Have Anticoagulants Stopped 3 Months</brief_title>
	<detailed_description />
	<mesh_term>Thrombosis</mesh_term>
	<mesh_term>Embolism</mesh_term>
	<mesh_term>Venous Thromboembolism</mesh_term>
	<mesh_term>Pulmonary Embolism</mesh_term>
	<mesh_term>Venous Thrombosis</mesh_term>
	<mesh_term>Anticoagulants</mesh_term>
	<mesh_term>Fibrin fragment D</mesh_term>
	<criteria>1 . Be &gt; = 18 year age 2 . Have ONE episode unprovoked proximal DVT and/or PE 3 . Have complete 3 uninterrupted month warfarin therapy ( target INR 2.03.0 ) 1 . Another indication longterm anticoagulation ( e.g. , atrial fibrillation ) 2 . A high risk bleed evidence follow : Age great 75 year Previous episode major bleed cause effectively treat Known chronic thrombocytopenia platelet count le 120,000 x 10^9 /L Known chronic renal impairment creatinine 150 mumols /litre ( 1.7 mg/dl ) Known chronic liver disease total bilirubin 25 mumols /litre ( 1.5 mg/dl ) Active peptic ulcer disease Poor compliance , control , anticoagulant therapy initial treatment Requires dual antiplatelet therapy ( e.g . aspirin clopidogrel ) 3 . A vena caval filter 4 . Has Ddimer test perform within 2 month potential enrollment evaluation suspect recurrent VTE confirm 5 . Has life expectancy le 5 year 6 . Is unable attend followup visit geographic inaccessibility 7 . Is participate compete clinical investigation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>75 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>unprovoked deep vein thrombosis</keyword>
	<keyword>unprovoked pulmonary embolism</keyword>
	<keyword>anticoagulant therapy</keyword>
</DOC>